Isolated pulmonary and renal IgG4-related disease: a rare dual-organ presentation diagnosed via video-assisted thoracoscopic surgery Authors: Natsumi Yazaki, Yuka Katsurada, Takehiro Okumura, Soichiro Ueda Published: 2026 ABSTRACT SummaryIgG4-related disease (IgG4-RD) is a systemic fibroinflammatory disorder that typically presents with multiorgan involvement. Herein, we report a rare phenotype in which the disease was confined solely to the kidneys and lungs. A man in his 60s presented with a 6-month history of cough and exertional dyspnoea. Imaging revealed bilateral renal enlargement with decreased enhancement, compatible with IgG4-related kidney disease, whereas the pulmonary findings were atypical for IgG4-related lung disease and radiologically mimicked non-specific interstitial pneumonia, making it difficult to determine whether the pulmonary lesions represented part of the same disease process or a separate interstitial lung disease. Serological findings indicated IgG4-RD. To clarify whether both organs were affected by a single systemic process, a thoracoscopic surgical lung biopsy was performed. The histopathological examination confirmed IgG4-positive plasma cell-rich inflammation establishing the diagnosis of IgG4-RD. Corticosteroid therapy resulted in radiological and clinical improvements of both organs. Histopathological evaluation of the lung lesions enabled a unified diagnosis of both the renal and pulmonary manifestations. A stepwise diagnostic approach using lung biopsy facilitated accurate diagnosis and effective treatment. Background IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory disorder characterised by IgG4-positive plasma cell-rich lymphoplasmacytic infiltration and variable fibrosis across multiple organs.1 The disease typically evolves over months to years and can lead to progressive organ dysfunction if diagnosis and treatment are delayed.2 Although IgG4-RD generally responds well to immunosuppressive therapy, relapse is common. The reported recurrence rates are approximately 17%, 26% and 33% at 12, 24 and 36 months, respectively; thus, long-term disease monitoring and prolonged immunosuppressive treatment are necessary.3 The prevalence of this disease has been increasing worldwide, with estimates of 0.28–1.08 per 100 000 in Asia (including Japan) and 1.39 per 100 000 in the USA.1 4 Multiorgan involvement often occurs; an international cohort reported organ manifestations in 75.6% of patients, which underscores the systemic nature of the disease.5 IgG4-RD also demonstrates variable organ tropism; the most commonly affected sites are the pancreas (approximately 48%–65%), biliary tract (35%–49%), lymph nodes (40%–42%) and kidneys (30%–38%).6 7 The clinical presentation is heterogeneous, and diagnosis may be challenging because radiological findings can overlap with those of malignancy, sarcoidosis, multicentric Castleman disease, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, and various interstitial lung diseases.7 8 Although thoracic or renal involvement may occur, organ-limited disease is uncommon and involvement confined solely to the lungs and kidneys is considered rare.710 In such cases, establishing a unifying diagnosis requires careful integration of clinical findings, imaging, serological evaluation and histopathological confirmation.79 Herein, we report a rare phenotype of IgG4-RD limited solely to the kidneys and lungs. Case presentation A Japanese man in his 60s presented with a 6-month history of cough and exertional dyspnoea after an abnormal chest radiograph was obtained during routine health screening. His medical history included hypothyroidism, hypertension and dyslipidaemia under treatment for 1 year, and right inguinal hernia repair in his early 40s. He never smoked and consumed approximately 500 mL of beer daily. There was no identifiable history of inhalational exposure. On examination, vital signs were stable (blood pressure 144/97 mmHg, heart rate 81 beats/min, body temperature 36.3°C and oxygen saturation 96% on room air). The patient was alert and well-oriented. No conjunctival pallor or palpable superficial lymphadenopathy was observed, and lung auscultation was unremarkable. Peripheral oedema, cutaneous eruption or clinical features suggestive of an underlying connective tissue disorder were not observed. Investigations The initial laboratory tests revealed elevated serum soluble interleukin-2 receptor 1680 kU/L (normal range 157–474 kU/L), IgG 34.5 g/L (normal range 8.61–17.47 g/L), IgG4 13.6 g/L (normal range 0.11–1.21 g/L), IgE 456 kU/L and KL-6 1806 kU/L (normal range <500 kU/L) levels. The eosinophil count was 0.232×109/L. Renal impairment was evident due to the levels of blood urea nitrogen 9.6 mmol/L (normal range 2.5–7.8 mmol/L) and creatinine of 149 μmol/L (normal range 53–97 μmol/L). Angiotensin-converting enzyme level was 10.3 U/L (normal range 8.3–21.4 U/L). Atypical lymphocytes were not detected. Autoantibodies for connective tissue diseases, bird-specific IgG antibodies and Trichosporon asahii antibodies were absent. Chest radiography demonstrated bilateral ground-glass opacities. Contrast-enhanced chest CT revealed diffuse lower-lobe-predominant ground-glass opacities without honeycombing, bronchovascular bundle thickening, traction bronchiectasis, scattered small pulmonary nodules and mild mediastinal lymphadenopathy. Abdominal contrast-enhanced CT showed bilateral renal enlargement with extensive, poorly enhanced areas (figure 1). Bronchoscopy was performed to determine the cause of the interstitial lung lesions. The bronchoalveolar lavage fluid obtained from the right lower lobe was clear, with a total cell count of 1575 cells/mL and lymphocyte predominance. The CD4/CD8 ratio was 0.85. The microbiological cultures were negative for common bacteria, fungi and mycobacteria, and malignant cells were not observed in the cytological analysis. Serial radiological findings before and after treatment. The images labelled A–C in the top row show findings before treatment, whereas those labelled D–F in the bottom row show findings after corticosteroid therapy. (A) Chest radiograph showing bilateral ground-glass opacities, predominantly in the lower lung fields. (B) Chest CT showing diffuse lower-lobe-predominant ground-glass opacities without honeycombing, bronchovascular bundle thickening or traction bronchiectasis, as well as scattered small pulmonary nodules. (C) Abdominal CT showing bilateral renal enlargement with extensive poorly enhancing areas. (D) Chest radiograph showing marked improvement of bilateral ground-glass opacities in the lower lung fields. (E) Chest CT showing substantial resolution of diffuse lower-lobe-predominant ground-glass opacities. (F) Abdominal CT showing resolution of bilateral renal enlargement and disappearance of previously noted poorly enhancing renal lesions. Histopathology Given the clinical suspicion of IgG4-RD, a video-assisted thoracoscopic (VATS) lung biopsy was performed in segment 8 of the right lower lobe. The histopathological examination revealed moderate-to-marked lymphoplasmacytic infiltration predominantly involving the interlobular and peribronchiolar regions. Inflammatory cell infiltration of the vessel walls and obliterative phlebitis were observed. The fibrosis was mild and focal, without storiform fibrosis or honeycomb changes. Immunohistochemical analysis showed an IgG4-positive/IgG-positive plasma cell ratio of 55% (110/200) (figure 2). Small nodules at the specimen margins were identified as intrapulmonary lymph nodes and were not considered a part of the IgG4-RD lesions. Histopathological findings of the lung biopsy. (A) Lymphoplasmacytic infiltration involving the interlobular and peribronchiolar regions (H&E ×40). (B) Dense interlobular lymphoplasmacytic infiltration with obliterative phlebitis (H&E ×200). (C) Elastic van Gieson staining highlighting focal obliterative phlebitis (×200). (D) Marked lymphoplasmacytic infiltration (H&E ×400). (E) IHC staining for IgG showing numerous IgG-positive plasma cells (×400). (F) IHC staining for IgG4 showing abundant IgG4-positive plasma cells, with an IgG4-positive/IgG-positive plasma cell ratio of approximately 55% (110/200; ×400). IHC, immunohistochemical. Outcome and follow-up Oral prednisolone was initiated at a dose of 0.6 mg/kg/day (40 mg/day). The dose was gradually tapered every 2–4 weeks according to clinical symptoms, laboratory findings and radiological improvement. Follow-up CT at 32 weeks after initiation of corticosteroid therapy demonstrated marked improvement in ground-glass opacities in both lower lobes, resolution of bilateral renal enlargement, disappearance of poorly enhanced renal lesions and regression of lymphadenopathy (figure 1). Pulmonary function testing and laboratory assessment at 22 weeks showed improvement in forced vital capacity from 3.22 L (94% predicted) at baseline to 3.41 L (100% predicted) at 22 weeks. Serum creatinine improved from 149 μmol/L at baseline to 118 μmol/L at 22 weeks, and estimated glomerular filtration rate improved from 32 mL/min/1.73 m² to 41 mL/min/1.73 m². During follow-up, no clinical, radiological or laboratory evidence of relapse of IgG4-RD was observed. The patient was followed monthly, and the prednisolone dose was tapered gradually every 2–4 weeks. At the time of writing this report, the patient remained on tapering steroid therapy. Key laboratory and pulmonary function data before and after corticosteroid therapy are summarised in table 1. Table 1Clinical and laboratory findings before and after corticosteroid therapyParameterBaseline22 weeks after corticosteroid therapySerum creatinine, μmol/L149118eGFR, mL/min/1.73 m23241FVC, L (% predicted)3.22 (94%)3.41 (100%)eGFR, estimated glomerular filtration rate; FVC, forced vital capacity. Clinical and laboratory findings before and after corticosteroid therapy eGFR, estimated glomerular filtration rate; FVC, forced vital capacity. Discussion In the present case, contrast-enhanced CT revealed bilateral renal enlargement with reduced enhancement, suggestive of IgG4-related kidney disease (IgG4-RKD).11 Although these findings strongly support the diagnosis, kidney-limited IgG4-RKD is considered uncommon because IgG4-RD typically presents with multisystem involvement rather than isolated organ disease.610 Furthermore, the patchy inflammatory distribution characteristic of IgG4-RKD increases the likelihood of sampling errors in percutaneous biopsy, potentially limiting diagnostic sensitivity.9 Given the characteristic renal imaging findings and the potential sampling error associated with renal biopsy, lung biopsy was considered the most informative approach for establishing a histopathological diagnosis. Conversely, a major diagnostic challenge in the present case was determining whether the pulmonary lesions represented IgG4-related lung disease (IgG4-RLD) or an independent interstitial lung disease coexisting with IgG4-RKD. Thoracic CT findings in IgG4-RLD are heterogeneous and include peribronchovascular thickening (56%), lymphadenopathy (31%), nodular lesions (25%), interstitial abnormalities (25%) and ground-glass opacities (10%).8 NSIP-like interstitial involvement is distinctly uncommon. In contrast, the present case showed only diffuse ground-glass opacities with an NSIP-like pattern without other typical thoracic manifestations of IgG4-RLD, which contributed to the diagnostic difficulty. Therefore, radiological findings alone were insufficient to establish a unified diagnosis. Because the pulmonary lesions lacked typical features of IgG4-RLD, it remained uncertain whether they represented part of the same IgG4-RD process or a separate interstitial lung disease. Therefore, histopathological confirmation of the pulmonary lesions was considered essential. Establishing IgG4-RLD by lung biopsy also enabled a definitive diagnosis of IgG4-RKD according to the 2020 revised comprehensive diagnostic criteria for IgG4-RD.12 NSIP-like IgG4-RLD has been previously described; however, it remains distinctly uncommon.1315 In a study by Muller et al,8 interstitial abnormalities were observed in 25% of a thoracic cohort with 48 patients. However, in a larger registry cohort comprising 724 patients, only 9.4% had interstitial lung disease, including 8 patients with an NSIP pattern. These findings reinforce that an NSIP pattern alone cannot confirm IgG4-RLD or distinguish it from other interstitial lung diseases, and that histopathological evaluation is required to exclude malignancy, sarcoidosis, multicentric Castleman disease, ANCA-associated vasculitis and other interstitial lung diseases.7 Although the BAL CD4/CD8 ratio was not elevated, bronchoalveolar lavage findings in IgG4-RLD are variable and are not considered diagnostic. Current clinicopathological recommendations emphasise that histopathological confirmation should be obtained whenever feasible because serological or radiological findings alone are insufficient for a definitive diagnosis of IgG4-RD.7 This case fulfilled the 2020 revised comprehensive diagnostic criteria for definite IgG4-RD based on characteristic renal imaging abnormalities, elevated serum IgG4 levels and histopathological evidence of IgG4-positive plasma cell-rich infiltration in an extrarenal organ.12 Pathologic examination of the VATS biopsy specimen demonstrated marked lymphocytic infiltration of IgG4-positive plasma cells, thereby enabling the unified diagnosis of IgG4-RKD and IgG4-RLD as components of a single systemic IgG4-RD process. Further, the epidemiological data of the present case support the rarity of this condition. In a nationwide Japanese survey excluding autoimmune pancreatitis, renal involvement was identified in 57 of the 5190 cases, whereas pulmonary involvement was observed in 354 of those cases, indicating that organ-limited disease is uncommon and that combined kidney-lung involvement is exceptionally rare.10 Although thoracic involvement occurs in up to 30% of IgG4-RD cases and may represent the sole manifestation in approximately 10%, epidemiological data specifically addressing lung-kidney-limited phenotypes remain scarce.8 This case represents a rare phenotype of IgG4-RD limited solely to the kidneys and lungs. Even when pulmonary imaging findings are atypical, a stepwise diagnostic approach is crucial for establishing an accurate diagnosis of IgG4-RD and determining an effective treatment strategy. In such settings, IgG4-RD should remain in the differential diagnosis when renal involvement is present, and histopathological evaluation of the organ most likely to yield a definitive diagnosis is essential. Learning points IgG4-related disease (IgG4-RD) involvement limited solely to the kidneys and lungs is rare and may present with atypical findings, such as an NSIP-like lung pattern. IgG4-related disease (IgG4-RD) involvement limited solely to the kidneys and lungs is rare and may present with atypical findings, such as an NSIP-like lung pattern. When renal and pulmonary lesions coexist, IgG4-RD should be included in the differential diagnosis, even if imaging findings are not characteristic. When renal and pulmonary lesions coexist, IgG4-RD should be included in the differential diagnosis, even if imaging findings are not characteristic. In patients with suspected IgG4-RD with concurrent renal and pulmonary involvement, a stepwise diagnostic approach, including histopathological evaluation of the organ with the highest diagnostic yield, is essential. In patients with suspected IgG4-RD with concurrent renal and pulmonary involvement, a stepwise diagnostic approach, including histopathological evaluation of the organ with the highest diagnostic yield, is essential.